comparemela.com

Latest Breaking News On - Segmentation by route of administration - Page 7 : comparemela.com

Global Plasma Protein Therapeutics Market to Reach $28 11 Billion in 2023, Driven by Product Innovations and Increasing Prevalence of Autoimmune Disorders

/PRNewswire/ The "Plasma Protein Therapeutics Global Market Report 2023" report has been added to ResearchAndMarkets.com s offering. This comprehensive.

United statesUnited kingdomSouth koreaProthya biosolutionsLaura woodBaxter international incReliance life sciences privateBio products laboratory ltdChina biologic products holdings incEmergent biosolutions incOffice hours callShire plcMp biomedicalsTiancheng germany pharmaceutical holdingsTakeda pharmaceutical companyBiologics inc

Global Lactose Intolerance Treatment Market to Experience Steady Growth to 2032: Driven by Increasing Incidences of Small Intestine Diseases and Product Innovations

/PRNewswire/ The "Lactose Intolerance Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com s offering. According to the.

United statesUnited kingdomSouth koreaWalter bushnellNovo nordiskLaura woodProfarma distribuidora produtos farmaceuticosDeerland probiotics enzymes incJohnson services incLupin pharmaceuticals incSun pharmaceutical industries ltdAmgen incGaneden incGelda scientific and industrial developmentOffice hours callAbbott laboratories

Global Calcium Channel Blocker Market Expected to Reach $14 66 Billion in 2023, Fueled by Increasing Prevalence of Cardiovascular Diseases

/PRNewswire/ The "Calcium Channel Blocker Global Market Report 2023" report has been added to ResearchAndMarkets.com s offering. The global calcium channel.

South koreaUnited statesUnited kingdomLaura woodAmneal pharmaceuticalsZydus groupLupin pharmaceuticals incOffice hours callPfizer incArbor pharmaceuticalsSofgen pharmaceuticalsBausch health companies incAzurity pharmaceuticalsE st office hours callGlenmark pharmaceuticals incChannel blocker global market report

Global Branded Generics Market to Reach $464 58 Billion by

Dublin, July 14, 2023 (GLOBE NEWSWIRE) The "Branded Generics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. .

United statesSouth koreaSaudi arabiaUnited arab emiratesUnited kingdomAurobindo pharmaZydus cadilaOther routes of administrationReddy laboratories ltdSun pharmaceutical industries ltdViatris incBiocon ltdTeva pharmaceutical industries ltdValeant pharmaceuticals international incRoche ltdPfizer inc

Generic Central Nervous System Drugs Global Market Report 2023: Major Players Include Otsuka Pharmaceutical, Astra Zeneca, Shire, Novartis and Teva Pharmaceutical Industries

/PRNewswire/ The "Generic Central Nervous System Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com s offering. This report.

South koreaUnited statesUnited kingdomLaura woodBristol myers squibbBaergic bioAstra zenecaEli lillyJanssen pharmaceuticals incAbbvie incMerck coEisai coNeurocrine biosciences incShire plcE st office hours callTeva pharmaceutical industries ltd

vimarsana © 2020. All Rights Reserved.